FDA Inspection 1155775 — Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
The FDA completed an inspection of Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy on October 26, 2021 in Murrieta, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 26, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Murrieta, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 18938 | FDCA 501(a)(2)(A) | Hazardous drugs, prevention of cross-contamination |